Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells

Bala Chandran1

  • 1H.M. Bligh Cancer Research Laboratories, Dept. of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois 60064, USA. bala.chandran@rosalindfranklin.edu

Journal of Virology
|November 20, 2009
PubMed

Insights

Kaposi's sarcoma-associated herpesvirus (KSHV) infection involves early cellular events, including how the virus enters cells and influences host gene expression. KSHV manipulates host cell signaling pathways for successful infection and pathogenesis.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Kaposi's sarcoma-associated herpesvirus (KSHV) is a significant human pathogen.
  • Understanding KSHV's early infection mechanisms is crucial for developing antiviral strategies.

Purpose of the Study:

  • To review current knowledge on the early stages of KSHV infection.
  • To elucidate the role of host cell signaling pathways in KSHV pathogenesis.

Main Methods:

  • Literature review of studies on KSHV infection.
  • Analysis of virus-receptor interactions and entry mechanisms.
  • Examination of viral and host gene expression during early infection.

Main Results:

  • KSHV utilizes specific envelope glycoproteins for cell entry.
  • Intracellular trafficking pathways are essential for KSHV infection.
  • KSHV actively manipulates host cell signaling pathways to facilitate infection.

Conclusions:

  • Early KSHV infection is a complex process involving intricate virus-host interactions.
  • Host cell signaling manipulation is a key strategy for KSHV pathogenesis.
  • Further research into these early events can inform therapeutic interventions.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...